ACIU

AcronymDefinition
ACIUArbejdsmarkedets Center for Internationale Uddannelsesaktiviteter (Danish: Social Center for International Training; Denmark)
ACIUAdvanced Central Interface Unit
ACIUAUTODIN Conferencing Interface Unit
ACIUAbiriba Communal Improvement Union (Nigeria)
ACIUAllied Counterintelligence Unit
References in periodicals archive ?
Aciu visiems uz grazias idejas ir suremtus pecius musu krastovaizdzio labui.
Senior council officer Trevor Gough accepted the gift and said: "I believe the Lithuanian phrase is 'lqbai aciu', which means 'thank you very much'."
But be careful if you sneeze - "Aciu", pronounced "achoo" means "thank you".
Release date- 14082019 - LAUSANNE - AC Immune SA (NASDAQ: ACIU), a Swiss-based, biopharmaceutical company with a broad clinical-stage pipeline focused on neurodegenerative diseases, today announced its business and clinical plan and strategy, reported consolidated financial results for the second quarter of 2019 and its revised cash guidance.
Andrea Pfeifer, Ph.D., CEO of AC Immune (ACIU), commented: "Our two proprietary discovery platforms, SupraAntigen and Morphomer, have generated multiple product-candidates utilizing different approaches to treating neuro-degenerative diseases.
Release date- 12082019 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced a research partnership with leading scientists in the Perelman School of Medicine at the University of Pennsylvania (Penn) focused on studying the pathological mechanisms of TDP-43 misfolding and aggregation.
Release date- 01082019 - LAUSANNE - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced the initiation of a Phase 1b/2a clinical trial to evaluate ACI-35.030, an anti-phospho-Tau (anti-pTau) vaccine.
AC Immune (ACIU) announced that Roche (RHHBY), the parent company of its collaboration partner, is discontinuing the CREAD 1 and CREAD 2 Phase III studies of the investigational anti-beta-amyloid molecule, crenezumab, in people with prodromal to mild sporadic Alzheimer's disease, or AD.
AC Immune (ACIU) and WuXi Biologics (WXXWY) announced the first steps of an exclusive strategic collaboration that covers biologics discovery, development and manufacturing.
Eli Lilly (LLY) and AC Immune (ACIU) announced that the two companies have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment of Alzheimer's disease, or AD, and other neurodegenerative diseases.